mopidamol has been researched along with Malignant Melanoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harvey, HA; Leitzel, KE; Lipton, A; Wolf, LM | 1 |
| Ambrus, CM; Ambrus, JL; Biddle, W; Gastpar, H; Horoszewicz, J; Huberman, E; Leong, S; Montagna, R | 1 |
| Gomez, J; Maniglia, CA; Sartorelli, AC; Tudor, G | 1 |
| Akhtar, S; Ambrus, JL; Koreshi, A; Kulaylat, M; Stadler, I | 1 |
| Hellmann, K; Hutchinson, G; Lichtner, RB; Wedderburn, N | 1 |
1 review(s) available for mopidamol and Malignant Melanoma
| Article | Year |
|---|---|
Antiplatelet pyrimido-pyrimidines and metastasis.
Topics: Animals; Blood Platelets; Cyclic AMP; Humans; Lung Neoplasms; Melanoma; Mice; Mopidamol; Neoplasm Metastasis; Platelet Aggregation; Pyrimidines; Rats | 1985 |
4 other study(ies) available for mopidamol and Malignant Melanoma
| Article | Year |
|---|---|
The in vitro interaction of RA-233 and several interferons on human cell lines.
Topics: Breast Neoplasms; Cell Division; Cell Line; Drug Synergism; Humans; Interferon Type I; Interferon-gamma; Melanoma; Mopidamol; Pyrimidines | 1984 |
Antimetastatic and antitumor effect of platelet aggregation inhibitors.
Topics: Animals; Female; Humans; Male; Melanoma; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Platelet Aggregation; Pyrimidines; Rats; Transplantation, Heterologous | 1982 |
The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanoma.
Topics: Animals; Cell Division; Female; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Mopidamol; Neoplasms, Experimental; Platelet Aggregation; Pyrimidines | 1982 |
Hemorrheologic effects of pyrimido-pyrimidine derivatives.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Antineoplastic Agents; Cell Division; Cyclic AMP; Erythrocyte Deformability; Hemorheology; Humans; Melanoma; Molecular Structure; Mopidamol; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrimidines; Tumor Cells, Cultured | 1996 |